Effects of DNA methyltransferase 1 inhibition on esophageal squamous cell carcinoma

Diseases of the Esophagus

Volumn 24, Issue 8, 2011, Pages 601-610

  Zhao, Shu Lei ^a   Zhu, Sheng Tao ^a   Hao, Xiaowen ^a   Li, Peng ^a   Zhang, Shu Tian ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

DNA methyltransferase 1; Esophageal squamous cell carcinoma; RNA interference

Indexed keywords

CADHERIN; DNA METHYLTRANSFERASE 1; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; METHYLTRANSFERASE; RETINOIC ACID RECEPTOR BETA; SMALL INTERFERING RNA; UBIQUITIN;

APOPTOSIS; ARTICLE; CANCER LOCALIZATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DNA METHYLATION; ENZYME INHIBITION; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; LYMPH NODE METASTASIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RNA INTERFERENCE; TUMOR DIFFERENTIATION; TUMOR SUPPRESSOR GENE;

APOPTOSIS; CADHERINS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; ESOPHAGEAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHATIC METASTASIS; O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE; PROMOTER REGIONS, GENETIC; RECEPTORS, RETINOIC ACID; RNA INTERFERENCE; RNA, MESSENGER; UBIQUITIN THIOLESTERASE; UP-REGULATION;

EID: 80855131581     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2011.01199.x     Document Type: Article

References (26)

1. Stewart B W, Kleihues P. World Cancer Report. Lyon: IARC Press, 2003.
2. Gamliel Z. Incidence, epidemiology and etiology of esophageal cancer. Chest Surg Clin N Am 2000; 10: 441-50.
3. Li P, Zhang S T, Yu Z L etal. Effects of cyclooxygenase-2 non-selective and selective inhibitors on proliferation inhibition and apoptosis induction of esophageal squamous carcinoma cells. Dis Esophagus 2009; 22: 21-31.
4. Zhou Q Z, Liu H B, Ding X C etal. Aspirin inhibits the proliferation of tobacco-related esophageal squamous carcinomas cell lines through cyclooxygenase 2 pathway. Chin Med J 2007; 120: 2086-91.
5. Hu H, Zhang S, Zhu S. Influence of aspirin and cigarette smoke extract on the expression of cyclin D1 and effects of cell cycle in esophageal squamous cell carcinoma cell line. Dis Esophagus 2009; 22: 310-16.
6. Zong Y, Zhang S T, Zhu S T. Nicotine enhances migration and invasion of human esophageal squamous carcinoma cells which is inhibited by nimesulide. World J Gastroenterol 2009; 15: 2500-5.
7. Wang Y, Fang M Z, Liao J etal. Hypermethylation-associated inactivation of retinoic acid receptor β in human esophageal squamous cell carcinoma. Clin Cancer Res 2003; 9: 5257-63.
8. Zhang L, Lu W, Miao X etal. Inactivation of DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation and its relation to p53 mutations in esophageal squamous cell carcinoma. Carcinogenesis 2003; 24: 1039-44.
9. Ying J, Li H, Seng T J etal. Functional epigenetics identifies a protocadherin PCDH10 as a candidate tumor suppressor for nasopharyngeal, esophageal and multiple other carcinomas with frequent methylation. Oncogene 2006; 25: 1070-80.
10. Yu J, Tao Q, Cheung K F etal. Epigenetic identification of ubiquitin carboxyl-terminal hydrolase L1 as a functional tumor suppressor and biomarker for hepatocellular carcinoma and other digestive tumors. Hepatology 2008; 48: 508-18.
11. Jeltsch A. Beyond Watson and Crick: DNA methylation and molecular enzymology of DNA methyltransferases. Chembiochem 2002; 3: 274-93.
12. Leu Y W, Rahmatpanah F, Shi H etal. Double RNA interference of DNMT3b and DNMT1 enhances DNA demethylation and gene reactivation. Cancer Res 2003; 63: 6110-15.
13. Mack G S. Epigenetic cancer therapy makes headway. J Natl Cancer Inst 2006; 98: 1443-4.
14. Jung Y, Park J, Kim T Y etal. Potential advantages of DNA methyltransferase 1 (DNMT1)-targeted inhibition for cancer therapy. J Mol Med 2007; 85: 1137-48.
15. Robert M F, Morin S, Beaulieu N etal. DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells. Nat Genet 2003; 33: 61-5.
16. Winquist E, Knox J, Ayoub J P etal. Phase II trial of DNA methyltransferase 1 inhibition with the antisense oligonucleotide MG98 in patients with metastatic renal carcinoma: a National Cancer Institute of Canada Clinical Trials Group investigational new drug study. Invest New Drugs 2006; 24: 159-67.
17. Etoh T, Kanai Y, Ushijima S etal. Increased DNA methyltransferase 1 (DNMT1) protein expression correlates significantly with poorer tumor differentiation and frequent DNA hypermethylation of multiple CpG islands in gastric cancers. Am J Pathol 2004; 164: 689-99.
18. Saito Y, Kanai Y, Nakagawa T etal. Increased protein expression of DNA methyltransferase(DNMT) 1 is significantly correlated with the malignant potential and poor prognosis of human hepatocellular carcinomas. Int J Cancer 2003; 105: 527-32.
19. Liao X, Siu M K, Chan K Y etal. Hypermethylation of RAS effector related genes and DNA methyltransferase 1 expression in endometrial carcinogenesis. Int J Cancer 2008; 123: 296-302.
20. Morey Kinney S R, Smiraglia D J, James S R etal. Stage-specific alterations of DNA methyltransferase expression, DNA hypermethylation, and DNA hypomethylation during prostate cancer progression in the transgenic adenocarcinoma of mouse prostate model. Mol Cancer Res 2008; 6: 1365-74.
21. Peng D F, Kanai Y, Sawada M etal. Increased DNA methyltransferase 1 (DNMT1) protein expression in precancerous conditions and ductal carcinomas of the pancreas. Cancer Sci 2005; 96: 403-8.
22. Herman J G, Baylin S B. Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 2003; 349: 2042-54.
23. Yoo C B, Jones P A. Epigenetic therapy of cancer: past, present and future. Nat Rev Drug Discov 2006; 5: 37-50.
24. Rhee I, Bachman K E, Park B H etal. DNMT1 and DNMT3b cooperate to silence genes in human cancer cells. Nature 2002; 416: 552-6.
25. Palii S S, Van Emburgh B O, Sankpal U T etal. DNA methylation inhibitor 5-Aza-2'-deoxycytidine induces reversible genome-wide DNA damage that is distinctly influenced by DNA methyltransferases 1 and 3B. Mol Cell Biol 2008; 28: 752-71.
26. Suzuki M, Sunaga N, Shames D S etal. RNA interference-mediated knockdown of DNA methyltransferase 1 leads to promoter demethylation and gene re-expression in human lung and breast cancer cells. Cancer Res 2004; 64: 3137-43.